GENASSIST™
CRISPR & rAAV Genome Editing Tools
Join the Program Now!
Visit www.horizondiscovery.com/guidebook
FREE CRISPR Reagents
for Knockout Generation
2
Horizon Discovery Ltd. 7100 Cambridge Research Park, UK
Our mission
“to translate the human genome and accelerate
the discovery of personalised medicines”
Tailoring the right drugs...to the right patients...at the right time
The opportunity: translating genetic information into personalised medicines
 Information is no longer a bottleneck, emphasis is shifting to the ‘what does it all
mean’
 Genome editing is enabling the promise of the genomic era to be realized in the
form of novel therapeutics and diagnostics
 It involves the capability to efficiently introduce targeted alterations into any
specific gene in living cells
3
GENESIS™: Comprehensive genome editing
rAAV
• High precision / low thru-put
• Any locus, wide cell tropism
• Well validated, KI focus
Zinc Fingers
• Med precision / med thru-put
• Good genome coverage
• Well validated / KO Focus
CRISPR
• New but high potential
• Capable of multi-gene targeting
• Simple RNA-directed cleavage
• Combinable with AAV
4
 Horizon is the only source of rAAV expertise and is uniquely capable of exploiting
multiple platforms: CRISPR, ZFNs and rAAV singularly or combined
Horizon’s scientists are experts at all forms of gene editing and so have the experience to help guide
customers towards the approach that best suits their project
5
Nucleases: CRISPR/ Cas9 System
RNA-guided platform to introduce either a double strand DNA break or a
single strand nick at a specified location in the genome.
 Short ‘guide’ RNAs with homology to target loci direct a generic nuclease (Cas9)
 Two versions of Cas9 (wt & nickase)
 Guide RNA + Cas9 are delivered into the cell
 Cas9 cleavage is repaired by either NHEJ, or HDR in tandem with a donor
 KO/KI efficiencies are high; specificity concerns now starting to be addressed
On the surface…
 Genome editing with CRISPR appears as simple as:
• Identifying a gRNA target sequence
• Ordering an oligo with the target sequence and cloning it into a gRNA vector
• Transfecting cells with the gRNA + Cas9
... HOWEVER …
6
Considerations when designing a gene editing experiment
 Gene target specifics
 Suitability of your cell line
 gRNA design
 gRNA activity
 Donor design
Considerations when designing a gene editing experiment
 Gene target specifics
 How many copies of your gene exist in your cell line?
 Do you need to modify all of them?
 Will the genetic change affect growth?
 Would KO of one allele and modification of the other be viable/acceptable?
 Suitability of your cell line
 gRNA design
 gRNA activity
 Donor design
Normal human karyotype
HeLa cell karyotype
8
Considerations when designing a gene editing experiment
 Gene Target Specifics
 Suitability of your cell line
 Does it transfect/electroporate well?
 Can the cells be single-cell diluted and recover?
 What are the optimal growth conditions?
 gRNA design
 gRNA activity
 Donor design
9
Considerations when designing a gene editing experiment
 Gene Target Specifics
 Suitability of your cell line
 gRNA design
 What sequence source are you using?
 What is the best guide sequence?
 How close is the guide to the desired
mutation?
 What are the potential off-target
considerations?
 Do you want to use wild-type Cas9 or the
mutant nickase version?
 gRNA activity
 Donor design
10
Considerations when designing a gene editing experiment
 Gene Target Specifics
 Suitability of your cell line
 gRNA design
 gRNA activity
 How many gRNAs need to be tested?
 How will you assess activity?
 What activity level do you need?
 Donor design
Considerations when designing a gene editing experiment
 Gene Target Specifics
 Suitability of your cell line
 gRNA design
 gRNA activity
 Donor design
 What if my donor is longer than an oligo?
 Will expression or splicing be affected?
 What type of donor do I use? (oligo, plasmid, AAV?)
 Should I use selection to enhance recovery of targeted
clones?
CRISPR and rAAV Intellectual property
Horizon is committed to gaining access to the widest range of CRISPR IP possible. We have
taken this approach to ensure that our customers and partners are secure in the knowledge
that they have the freedom to pursue their research and commercial goals when they
choose to work with us.
We bring to our customers the widest breadth of IP available from any commercial source,
and we currently have either already taken a license to or are in late-stage negotiations to
access multiple separate CRISPR IP patent estates:
 We have entered into a non-exclusive license agreement with ERS Genomics Ltd (ERS) ,
Harvard and with the Broad Institute to access intellectual property (IP) relating to the
CRISPR/Cas9 gene editing system
 Horizon is the only company with access to rAAV as a precise gene editing or
DNA/plasmid delivery platform, we are the only company able to offer hybrid
rAAV/CRISPR systems that draw from the best aspects of both approaches for far superior
gene editing efficiencies.
14
Horizon’s unique capabilities: Combining rAAV + CRISPR
Technologies can be combined for
improved efficiency
 Tested using a reporter cell-line
harboring an inactivating mutation in
GFP
 Correction donor-vector supplied either
as dsPlasmid, ssDNA oligos, or ssDNA
rAAV
 rAAV = the most efficient donor vector
(50 fold)
%Greencells(FACs)
15
GENASSIST™ CRISPR and rAAV enabled gene editing
 Cas9 wild type, nickase and Off the Shelf cloning plasmids
 Guide RNA Design, Manufacturing and Validation service
 Donor Design, Manufacturing (Oligo, Plasmids & rAAV)
 Viral encapsulation (Adenoviral vectors)
 Gene editing expert support
 Cell Lines available for further gene editing
• HEK293 expressing Cas9 nickase
• Over 550 Genetically defined Mutant cell lines (X-MAN™)
16
Off the Shelf Plasmid Library
Horizon has a variety of off the shelf plasmids available to address all your gene editing
requirements
 gRNA and Donor cloning vectors
 GFP and Puromycin selection available
 All-in-one gRNA(s) + Cas9
 Cas9 insertion into Rosa26 Locus
Guide RNA design, cloning and validation
Target
identified
In silico guide
design
Report
Cloning into
all-in-one
vector
Package into
adenovirus
Report and
oligo(s)
Report and
clone(s)
17
Validation
18
Donor design and cloning/ viral packaging
Optimized processes for short (<200 bp) donors that utilize Horizon’s deep
gene editing expertise to maximize your chances of success
Longer donors can be provided as plasmid, rAAV or Adeno
Donor for insertion of Best-in-class reporter tags HaloTag® and Nanoluc®
Sequencing service
K-Ras HaloTag® cells labelled with
HaloTag® ligand (red) and a DNA
stain (green)
19
gUIDEbook™
Horizon Discovery partnered with Desktop Genetics to develop gUIDEbook™.
Designed by experts in the field of CRISPR genome editing, gUIDEbook™
addresses the needs of any researcher using CRISPR for generating knock-
outs, knock-ins, mutations or tags.
State of the art scoring functions
Custom scoring functions and custom genomic data
Forms pairs of gRNAs for use with nickase mutant Cas9
Design a donor sequence for knock-in experiments and silencing a target
cut site by possible silent mutations
20
Expert gene editing Support
Horizon scientists have created hundreds of cell lines and truly understand
challenges and needs of gene editing
We offer tools, reagents and cell lines have been built with our expertise
Access to expert scientists that perform gene editing daily on multiple
technological platforms
21
Cell Lines available for gene editing
More than 550 mutant cell lines are now accessible for further gene
editing:
• Most important cancer mutations available
• Gene editing in a defined mutant background
Cas9 D10A nickase cell line and cell generation reagents
• Use HEK293 Cas9 nickase as workhorse for all your gene editing projects
• Generate new Cas9 transgenic cell lines with our plasmids to target ROSA26 locus
Horizon would like to license
your cell lines!
FREE CRISPR Knockout Generation Program
Open to all academic researchers for knock-out of human genes
Free guide design using gUIDEbook™, Horizon’s in silico guide design
software
Free cloning into an all-in one vector expressing Cas9 wt
Must let horizon know when your guide has been used to generate a cell
line
When possible, Horizon wants to license cell lines generated in return for a
royalty
Only pay cost of shipping
Possibility to validate guides before receiving them
22
Join the Program Now!
Visit www.horizondiscovery.com/guidebook

More Related Content

PPTX
CRISPR presentation extended Mouse Modeling
PPTX
Translating Genomes | Personalizing Medicine
PPSX
Genome Editing Comes of Age; CRISPR, rAAV and the new landscape of molecular ...
PPTX
Genome Editing Comes Of Age
PPTX
Rewriting the Genome Using CRISPR and Synthetic Biology
PPTX
CRISPR: Gene editing for everyone
PPTX
Genome editing comes of age
PPTX
Recent advances in CRISPR-CAS9 technology: an alternative to transgenic breeding
CRISPR presentation extended Mouse Modeling
Translating Genomes | Personalizing Medicine
Genome Editing Comes of Age; CRISPR, rAAV and the new landscape of molecular ...
Genome Editing Comes Of Age
Rewriting the Genome Using CRISPR and Synthetic Biology
CRISPR: Gene editing for everyone
Genome editing comes of age
Recent advances in CRISPR-CAS9 technology: an alternative to transgenic breeding

What's hot (20)

PPTX
Crispr/cas9 101
PPTX
CRISPR Screening: the What, Why and How
PPTX
CRISPR - gene-editing for everyone
PDF
Genome Editing CRISPR-Cas9
PDF
Lessons learned from high throughput CRISPR targeting in human cell lines
PDF
CRISPR-Cas9 Review: A potential tool for genome editing
PPTX
CRISPR: what it is, and why it is having a profound impact on human health
PPTX
the application of CRISPR/Cas9 system in genome editing
PPTX
Crispr
PPTX
CRISPR-Revolutionary Genome editing tools for Plants.....
PPTX
PPTX
The next generation of crispr–cas technologies and Applications
PPTX
Why we love crispr cas (and you should, too!)
PPTX
Making the cut with CRISPR
PPTX
PPTX
Genome Editing Comes of Age
PDF
CRISPR Agbio San Diego April 2017 Agenda
PPTX
CRISPR/Cas9 Platform
PPTX
Multi Target Gene Editing using CRISPR Technology for Crop Improvement
Crispr/cas9 101
CRISPR Screening: the What, Why and How
CRISPR - gene-editing for everyone
Genome Editing CRISPR-Cas9
Lessons learned from high throughput CRISPR targeting in human cell lines
CRISPR-Cas9 Review: A potential tool for genome editing
CRISPR: what it is, and why it is having a profound impact on human health
the application of CRISPR/Cas9 system in genome editing
Crispr
CRISPR-Revolutionary Genome editing tools for Plants.....
The next generation of crispr–cas technologies and Applications
Why we love crispr cas (and you should, too!)
Making the cut with CRISPR
Genome Editing Comes of Age
CRISPR Agbio San Diego April 2017 Agenda
CRISPR/Cas9 Platform
Multi Target Gene Editing using CRISPR Technology for Crop Improvement
Ad

Viewers also liked (8)

PPTX
Talen final
PPT
Transposone And Retrotransposone
PPT
RNA editing
PDF
New RNA tools for optimized CRISPR/Cas9 genome editing
PDF
Increase efficiency of genome editing with the Alt-R™ CRISPR-Cas9 System: Des...
PPTX
Reprogramming the genome with CRISPR
PPT
Gene therapy
PPTX
Gene editing 1
Talen final
Transposone And Retrotransposone
RNA editing
New RNA tools for optimized CRISPR/Cas9 genome editing
Increase efficiency of genome editing with the Alt-R™ CRISPR-Cas9 System: Des...
Reprogramming the genome with CRISPR
Gene therapy
Gene editing 1
Ad

Similar to GENASSIST™ CRISPR & rAAV Genome Editing Tools (20)

PPTX
Gene Editing for everyone
PPTX
Experimental Techniques and Limitations of CRISPR and Gene.pptx
PPTX
An Introduction to Crispr Genome Editing
PPTX
Gene Editing Technology. Excellent_JUNE 2024.pptx
PPTX
Gene Editing (Through CRISPR Cas9 Protein).pptx
PPTX
CRISPR-Cas9 mediated genome editing : A comprehensive review with zebrafish a...
PPTX
Crisper cas
PPTX
Gene drives
PPTX
The key considerations of crispr genome editing
PPTX
A New molecular biology techniques for gene therapy
PPTX
CRISPR/CAS9- THE GENE EDITING TOOL
PPTX
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
PDF
The Crisprcas Tool Kit For Genome Editing Aftab Ahmad Sultan Habibullah Khan
PDF
CRISPR+101.pdf
PPTX
Crispr Cas9 technique
PPTX
Application of crispr in cancer therapy
PDF
CRISPR - CAS 9 Gene Editing, Methods, Procedure and Ethical Consideration
PPTX
Crispr cas9
PPTX
crispr cas 9
PDF
Genome Editing Review - Recent Technologies & Potential Applications
Gene Editing for everyone
Experimental Techniques and Limitations of CRISPR and Gene.pptx
An Introduction to Crispr Genome Editing
Gene Editing Technology. Excellent_JUNE 2024.pptx
Gene Editing (Through CRISPR Cas9 Protein).pptx
CRISPR-Cas9 mediated genome editing : A comprehensive review with zebrafish a...
Crisper cas
Gene drives
The key considerations of crispr genome editing
A New molecular biology techniques for gene therapy
CRISPR/CAS9- THE GENE EDITING TOOL
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
The Crisprcas Tool Kit For Genome Editing Aftab Ahmad Sultan Habibullah Khan
CRISPR+101.pdf
Crispr Cas9 technique
Application of crispr in cancer therapy
CRISPR - CAS 9 Gene Editing, Methods, Procedure and Ethical Consideration
Crispr cas9
crispr cas 9
Genome Editing Review - Recent Technologies & Potential Applications

More from Candy Smellie (16)

PPTX
Blueprints to blue sky – analyzing the challenges and solutions for IHC compa...
PPTX
Understanding and controlling for sample and platform biases in NGS assays
PPTX
Resolving Ambiguity in Target ID Screens - CRISPR-Cas9 Based Essentiality Pro...
PPTX
Molecular QC: Interpreting your Bioinformatics Pipeline
PPTX
Identification and Prioritization of Drug Combinations for Treatment of Cancer
PPTX
Molecular QC: Using Reference Standards in NGS Pipelines
PPTX
Improving Immunohistochemistry Standardization in your Laboratory: Renewable ...
PPTX
Cell Free DNA comes to the Clinic
PPTX
Addressing the Pre-PCR Analytical Variability of FFPE Samples
PPTX
Using reference materials to meet validation & verification requirements for ...
PPTX
RNA-based screening in drug discovery – introducing sgRNA technologies
PPTX
To assess the effect of formalin on genomic DNA and assay performance for som...
PPTX
Overview of Quality Management System
PPTX
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
PPTX
Translating Genomes | Personalizing Medicine
PPTX
The clinical application development and validation of cell free dna assays -...
Blueprints to blue sky – analyzing the challenges and solutions for IHC compa...
Understanding and controlling for sample and platform biases in NGS assays
Resolving Ambiguity in Target ID Screens - CRISPR-Cas9 Based Essentiality Pro...
Molecular QC: Interpreting your Bioinformatics Pipeline
Identification and Prioritization of Drug Combinations for Treatment of Cancer
Molecular QC: Using Reference Standards in NGS Pipelines
Improving Immunohistochemistry Standardization in your Laboratory: Renewable ...
Cell Free DNA comes to the Clinic
Addressing the Pre-PCR Analytical Variability of FFPE Samples
Using reference materials to meet validation & verification requirements for ...
RNA-based screening in drug discovery – introducing sgRNA technologies
To assess the effect of formalin on genomic DNA and assay performance for som...
Overview of Quality Management System
HDx™ Reference Standards and Reference Materials for Next Generation Sequenci...
Translating Genomes | Personalizing Medicine
The clinical application development and validation of cell free dna assays -...

Recently uploaded (20)

PPTX
Understanding the Circulatory System……..
PPTX
perinatal infections 2-171220190027.pptx
PPT
THE CELL THEORY AND ITS FUNDAMENTALS AND USE
PDF
S2 SOIL BY TR. OKION.pdf based on the new lower secondary curriculum
PPTX
Microbes in human welfare class 12 .pptx
PPTX
Presentation1 INTRODUCTION TO ENZYMES.pptx
PDF
CHAPTER 2 The Chemical Basis of Life Lecture Outline.pdf
PPTX
A powerpoint on colorectal cancer with brief background
PDF
Is Earendel a Star Cluster?: Metal-poor Globular Cluster Progenitors at z ∼ 6
PDF
Worlds Next Door: A Candidate Giant Planet Imaged in the Habitable Zone of ↵ ...
PDF
Social preventive and pharmacy. Pdf
PPTX
Probability.pptx pearl lecture first year
PPTX
Seminar Hypertension and Kidney diseases.pptx
PPTX
endocrine - management of adrenal incidentaloma.pptx
PPTX
Substance Disorders- part different drugs change body
PDF
CHAPTER 3 Cell Structures and Their Functions Lecture Outline.pdf
PPT
Animal tissues, epithelial, muscle, connective, nervous tissue
PPTX
gene cloning powerpoint for general biology 2
PPT
veterinary parasitology ````````````.ppt
PPTX
POULTRY PRODUCTION AND MANAGEMENTNNN.pptx
Understanding the Circulatory System……..
perinatal infections 2-171220190027.pptx
THE CELL THEORY AND ITS FUNDAMENTALS AND USE
S2 SOIL BY TR. OKION.pdf based on the new lower secondary curriculum
Microbes in human welfare class 12 .pptx
Presentation1 INTRODUCTION TO ENZYMES.pptx
CHAPTER 2 The Chemical Basis of Life Lecture Outline.pdf
A powerpoint on colorectal cancer with brief background
Is Earendel a Star Cluster?: Metal-poor Globular Cluster Progenitors at z ∼ 6
Worlds Next Door: A Candidate Giant Planet Imaged in the Habitable Zone of ↵ ...
Social preventive and pharmacy. Pdf
Probability.pptx pearl lecture first year
Seminar Hypertension and Kidney diseases.pptx
endocrine - management of adrenal incidentaloma.pptx
Substance Disorders- part different drugs change body
CHAPTER 3 Cell Structures and Their Functions Lecture Outline.pdf
Animal tissues, epithelial, muscle, connective, nervous tissue
gene cloning powerpoint for general biology 2
veterinary parasitology ````````````.ppt
POULTRY PRODUCTION AND MANAGEMENTNNN.pptx

GENASSIST™ CRISPR & rAAV Genome Editing Tools

  • 1. GENASSIST™ CRISPR & rAAV Genome Editing Tools Join the Program Now! Visit www.horizondiscovery.com/guidebook FREE CRISPR Reagents for Knockout Generation
  • 2. 2 Horizon Discovery Ltd. 7100 Cambridge Research Park, UK Our mission “to translate the human genome and accelerate the discovery of personalised medicines” Tailoring the right drugs...to the right patients...at the right time
  • 3. The opportunity: translating genetic information into personalised medicines  Information is no longer a bottleneck, emphasis is shifting to the ‘what does it all mean’  Genome editing is enabling the promise of the genomic era to be realized in the form of novel therapeutics and diagnostics  It involves the capability to efficiently introduce targeted alterations into any specific gene in living cells 3
  • 4. GENESIS™: Comprehensive genome editing rAAV • High precision / low thru-put • Any locus, wide cell tropism • Well validated, KI focus Zinc Fingers • Med precision / med thru-put • Good genome coverage • Well validated / KO Focus CRISPR • New but high potential • Capable of multi-gene targeting • Simple RNA-directed cleavage • Combinable with AAV 4  Horizon is the only source of rAAV expertise and is uniquely capable of exploiting multiple platforms: CRISPR, ZFNs and rAAV singularly or combined Horizon’s scientists are experts at all forms of gene editing and so have the experience to help guide customers towards the approach that best suits their project
  • 5. 5 Nucleases: CRISPR/ Cas9 System RNA-guided platform to introduce either a double strand DNA break or a single strand nick at a specified location in the genome.  Short ‘guide’ RNAs with homology to target loci direct a generic nuclease (Cas9)  Two versions of Cas9 (wt & nickase)  Guide RNA + Cas9 are delivered into the cell  Cas9 cleavage is repaired by either NHEJ, or HDR in tandem with a donor  KO/KI efficiencies are high; specificity concerns now starting to be addressed
  • 6. On the surface…  Genome editing with CRISPR appears as simple as: • Identifying a gRNA target sequence • Ordering an oligo with the target sequence and cloning it into a gRNA vector • Transfecting cells with the gRNA + Cas9 ... HOWEVER … 6
  • 7. Considerations when designing a gene editing experiment  Gene target specifics  Suitability of your cell line  gRNA design  gRNA activity  Donor design
  • 8. Considerations when designing a gene editing experiment  Gene target specifics  How many copies of your gene exist in your cell line?  Do you need to modify all of them?  Will the genetic change affect growth?  Would KO of one allele and modification of the other be viable/acceptable?  Suitability of your cell line  gRNA design  gRNA activity  Donor design Normal human karyotype HeLa cell karyotype 8
  • 9. Considerations when designing a gene editing experiment  Gene Target Specifics  Suitability of your cell line  Does it transfect/electroporate well?  Can the cells be single-cell diluted and recover?  What are the optimal growth conditions?  gRNA design  gRNA activity  Donor design 9
  • 10. Considerations when designing a gene editing experiment  Gene Target Specifics  Suitability of your cell line  gRNA design  What sequence source are you using?  What is the best guide sequence?  How close is the guide to the desired mutation?  What are the potential off-target considerations?  Do you want to use wild-type Cas9 or the mutant nickase version?  gRNA activity  Donor design 10
  • 11. Considerations when designing a gene editing experiment  Gene Target Specifics  Suitability of your cell line  gRNA design  gRNA activity  How many gRNAs need to be tested?  How will you assess activity?  What activity level do you need?  Donor design
  • 12. Considerations when designing a gene editing experiment  Gene Target Specifics  Suitability of your cell line  gRNA design  gRNA activity  Donor design  What if my donor is longer than an oligo?  Will expression or splicing be affected?  What type of donor do I use? (oligo, plasmid, AAV?)  Should I use selection to enhance recovery of targeted clones?
  • 13. CRISPR and rAAV Intellectual property Horizon is committed to gaining access to the widest range of CRISPR IP possible. We have taken this approach to ensure that our customers and partners are secure in the knowledge that they have the freedom to pursue their research and commercial goals when they choose to work with us. We bring to our customers the widest breadth of IP available from any commercial source, and we currently have either already taken a license to or are in late-stage negotiations to access multiple separate CRISPR IP patent estates:  We have entered into a non-exclusive license agreement with ERS Genomics Ltd (ERS) , Harvard and with the Broad Institute to access intellectual property (IP) relating to the CRISPR/Cas9 gene editing system  Horizon is the only company with access to rAAV as a precise gene editing or DNA/plasmid delivery platform, we are the only company able to offer hybrid rAAV/CRISPR systems that draw from the best aspects of both approaches for far superior gene editing efficiencies.
  • 14. 14 Horizon’s unique capabilities: Combining rAAV + CRISPR Technologies can be combined for improved efficiency  Tested using a reporter cell-line harboring an inactivating mutation in GFP  Correction donor-vector supplied either as dsPlasmid, ssDNA oligos, or ssDNA rAAV  rAAV = the most efficient donor vector (50 fold) %Greencells(FACs)
  • 15. 15 GENASSIST™ CRISPR and rAAV enabled gene editing  Cas9 wild type, nickase and Off the Shelf cloning plasmids  Guide RNA Design, Manufacturing and Validation service  Donor Design, Manufacturing (Oligo, Plasmids & rAAV)  Viral encapsulation (Adenoviral vectors)  Gene editing expert support  Cell Lines available for further gene editing • HEK293 expressing Cas9 nickase • Over 550 Genetically defined Mutant cell lines (X-MAN™)
  • 16. 16 Off the Shelf Plasmid Library Horizon has a variety of off the shelf plasmids available to address all your gene editing requirements  gRNA and Donor cloning vectors  GFP and Puromycin selection available  All-in-one gRNA(s) + Cas9  Cas9 insertion into Rosa26 Locus
  • 17. Guide RNA design, cloning and validation Target identified In silico guide design Report Cloning into all-in-one vector Package into adenovirus Report and oligo(s) Report and clone(s) 17 Validation
  • 18. 18 Donor design and cloning/ viral packaging Optimized processes for short (<200 bp) donors that utilize Horizon’s deep gene editing expertise to maximize your chances of success Longer donors can be provided as plasmid, rAAV or Adeno Donor for insertion of Best-in-class reporter tags HaloTag® and Nanoluc® Sequencing service K-Ras HaloTag® cells labelled with HaloTag® ligand (red) and a DNA stain (green)
  • 19. 19 gUIDEbook™ Horizon Discovery partnered with Desktop Genetics to develop gUIDEbook™. Designed by experts in the field of CRISPR genome editing, gUIDEbook™ addresses the needs of any researcher using CRISPR for generating knock- outs, knock-ins, mutations or tags. State of the art scoring functions Custom scoring functions and custom genomic data Forms pairs of gRNAs for use with nickase mutant Cas9 Design a donor sequence for knock-in experiments and silencing a target cut site by possible silent mutations
  • 20. 20 Expert gene editing Support Horizon scientists have created hundreds of cell lines and truly understand challenges and needs of gene editing We offer tools, reagents and cell lines have been built with our expertise Access to expert scientists that perform gene editing daily on multiple technological platforms
  • 21. 21 Cell Lines available for gene editing More than 550 mutant cell lines are now accessible for further gene editing: • Most important cancer mutations available • Gene editing in a defined mutant background Cas9 D10A nickase cell line and cell generation reagents • Use HEK293 Cas9 nickase as workhorse for all your gene editing projects • Generate new Cas9 transgenic cell lines with our plasmids to target ROSA26 locus Horizon would like to license your cell lines!
  • 22. FREE CRISPR Knockout Generation Program Open to all academic researchers for knock-out of human genes Free guide design using gUIDEbook™, Horizon’s in silico guide design software Free cloning into an all-in one vector expressing Cas9 wt Must let horizon know when your guide has been used to generate a cell line When possible, Horizon wants to license cell lines generated in return for a royalty Only pay cost of shipping Possibility to validate guides before receiving them 22 Join the Program Now! Visit www.horizondiscovery.com/guidebook